James Bradner

This inventor holds 25 USPTO granted patents and 24 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Dana-Farber-Cancer Institute Inc., Harvard College, Acetylon Pharmaceuticals, Inc.. Active years: 2012-2024.

USPTO Granted Patents = 25 (Patent Applications = 24)

% Patents Active = 80.0

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 4 (Patent Applications = 18)

Average Co-Inventor Count = 3.6

ph-index = 10

Forward Citations = 213(Granted Patents)

Location History:

Cambridge, MA (US) (2012 - 2023)
Weston, MA (US) (2024)

Company Filing History:

19 out of 1,264

Dana-Farber-Cancer Institute Inc.

Acetylon Pharmaceuticals, Inc.

patents

4. 3 out of 488

Colorado State University Research Foundation

patents

5. 2 out of 385

University of Notre Dame Du Lac

patents

6. 1 out of 615

Baylor College of Medicine

patents

7. 1 out of 1,072

Children's Medical Center Corporation

patents

8. 1 out of 137

Howard Hughes Medical Institute

The Brigham and Women's Hospital, Inc.

patents

where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12129248 - Chromobox protein inhibitors and uses thereof (2024-10-29),

2. 12023385 - Tunable endogenous protein degradation with heterobifunctional compounds (2024-07-02),

3. 11999802 - Compositions and methods for selective protein degradation (2024-06-04),

4. 11944625 - Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies (2024-04-02),

5. 11617750 - Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof (2023-04-04),

6. 10525139 - Folate-conjugated molecules for delivery of toxic small molecule inhibitors to cancer cells and methods of use (2020-01-07),

7. 10172821 - Histone deacetylase inhibitors (2019-01-08),

8. 9789120 - Male contraceptive compositions and methods of use (2017-10-17),

9. 9724321 - Histone deacetylase inhibitors (2017-08-08),

10. 9434686 - Deacetylase inhibitors and uses thereof (2016-09-06),

11. 9199923 - Histone deacetylase inhibitors (2015-12-01),

12. 9186402 - Method for preparing largazole analogs and uses thereof (2015-11-17),

13. 9074009 - Stabilized MAML peptides and uses thereof (2015-07-07),

14. 8754237 - Bifunctional histone deacetylase inhibitors (2014-06-17),

15. 8716344 - Class- and isoform-specific HDAC inhibitors and uses thereof (2014-05-06),

Title: The Innovative Journey of James Bradner

Introduction: James Bradner is a renowned inventor based in Cambridge, MA (US) known for his groundbreaking contributions to the field of biotechnology and pharmaceuticals.

Latest Patents: James Bradner holds several patents related to novel cancer therapies and drug discovery methods, showcasing his commitment to innovation in healthcare.

Career Highlights: With a background in medicine and research, James Bradner has led numerous successful projects that have revolutionized the way we approach cancer treatment and drug development.

Collaborations: Throughout his career, James Bradner has collaborated with leading pharmaceutical companies, research institutions, and universities to further advance his inventions and bring them to the market.

Conclusion: James Bradner's dedication to pushing the boundaries of science and medicine through his inventions has solidified his reputation as a pioneering figure in the field of biotechnology.